At the same time the WHO set out their thinking
behind their new position
in a piece for the journal, PLOS Medicine, and they called for all regulators,
companies, academics, institutional research boards, universities, funders —
everybody who has a role
in this — to take up the challenge
in their own jurisdictions and make it happen.
Attempting to determine dosage amounts of a drug according to the generic recommendation that «this will work for
everybody» from a
company or business that is interested more
in making a sale than
in the health of the population is counterproductive to the initial impetus
behind taking the medication
in the first place.